Evaluation of Urine Samples and Their Relation to Urinary Tract Infection
Completed
- Conditions
- Urinary Tract Infections
- Registration Number
- NCT03522766
- Lead Sponsor
- Coloplast A/S
- Brief Summary
The aim is to explore the human urine composition and its relation to urine tract infections
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Have given written informed consent
- Be at least 18 years of age and have full legal capacity
- For the 2 patient populations: Use intermittent catheter on a daily basis due to neurogenic bladder or enlarged prostate and have used IC for at least 2 months
- For healthy volunteers without UTIs: No diag-nosed UTIs within the last year
- For healthy volunteers with recurrent UTIs: 3 or more UTIs within the last year or 2 UTIs within the last 6 months (treated with antibiotics)
Exclusion Criteria
- Be treated for urinary tract infection at time of enrolment
- May not take prophylactic treatment for urinary tract infections (antibiotics only)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Type of bacteria present in the urine 1 year The different bacteria isolated present in the urine will be identified
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link urine composition to urinary tract infection recurrence in NCT03522766?
How does Coloplast A/S observational study compare to standard-of-care diagnostics for UTIs?
What biomarkers in urine samples predict susceptibility to uropathogenic E. coli in NCT03522766?
Are there novel antimicrobial targets identified in urine metabolomics from this Coloplast trial?
What adverse event patterns emerge in UTI patients with altered urine biomarkers per NCT03522766?
Trial Locations
- Locations (1)
Coloplast A/S
🇩🇰Humlebæk, Denmark
Coloplast A/S🇩🇰Humlebæk, Denmark